New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
06:06 EDTGWPHCNN documentary supports GW's broad approach, says Piper Jaffray
Piper Jaffray believes Sanjay Gupta's CNN special last night entitled "Weed Part 2: Cannabis Madness" further validates GW Pharmaceuticals' broad approach to cannabinoid development. Piper believes GW's manufacturing capabilities and "superior" extraction processes were highlighted on the show. It keeps an Overweight rating on the stock with a $97 price target.
News For GWPH From The Last 14 Days
Check below for free stories on GWPH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 14, 2014
07:50 EDTGWPHGW Pharmaceuticals shares attractive ahead of data, says Leerink
After meeting with management, Leerink says is continue to view shares of GW Pharmaceuticals as attractive here ahead of additional Epidiolex data readouts and the commencement of pivotal trials in the second half of 2014. The firm reiterates an Outperform rating on the stock with a $110 price target.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use